Define Ventures

Define Ventures is a prominent venture capital firm specializing in early-stage digital health companies. With $800 million in assets under management, the firm invests in companies at the incubation, seed, Series A, and Series B stages. Their mission is to partner with entrepreneurs who challenge the conventional and remain convicted by what’s possible in healthcare.

The firm's investment strategy centers on companies that redefine healthcare through technology and innovation. They focus on sectors such as health and wellness platforms, community health technologies, and AI-driven clinical care solutions. Define Ventures emphasizes a principled approach to building impactful companies, aiming to shape the future of healthcare by supporting visionary founders.

Since its inception, Define Ventures has built a portfolio of category-defining companies, including Hims & Hers, Livongo, and Evolent Health. Their high-conviction, hands-on approach has led to significant exits, collectively delivering $23 billion in exit value. The firm's thoughtfully curated team brings together investors and founders who have built category-defining companies in this vision, collectively delivering $23 billion in exit value, including Livongo (LVGO), Evolent (NYSE: EVH), and Hims & Hers (NYSE: HIMS).